Ying Yu, MS, MD
Vice President and CSO
Ying has over 25 years of experience in cardiovascular, metabolic and chronic kidney disease research, drug discovery and development. During her 12-year career with Pfizer R&D, she served as the pharmacology leader of multiple pre-clinical project teams, generating IND-enabling pharmacology data packages and corresponding documentation responsible for the advancement of multiple quality lead drug candidates into clinical trials. She has in-depth knowledge of translational pharmacology and extensive experience in design and execution of pre-clinical pharmacology studies and data analysis and interpretation. Dr. Yu received an M.D. from Anhui Medical University, China, and a M.S. in Physiology from University of North Texas Health Science Center.